Find Academic Supervisors

Aleksandra CavoskiView profile

Professor

• Environmental Law
• EU Law
• Public International Law
• +12 more

Aleksandra Cavoski is a Professor of Law at the Birmingham Law School, University of Birmingham, and serves as Director of Global Engagement for the College of Arts and Law. She is also affiliated with the Birmingham Institute for Sustainability and Climate Action and the Centre for Environmental Research and Justice, reflecting her strong commitment to interdisciplinary and sustainability-focused legal scholarship. Her research lies at the intersection of environmental law, EU law, and public international law, with a particular focus on the connections between law and science, policy, and language. She explores how legal frameworks are shaped by social, political, and scientific contexts, especially in areas such as environmental governance, climate action, and regulatory innovation. Environmental Law EU Law Law and Science Legal Translation New Approach Methodologies (NAMs) Circular Economy and Plastics Regulation Energy Transition and Critical Minerals Her recent publications and research projects highlight a consistent focus on regulatory innovation and sustainability, particularly in the use of NAMs for chemical safety, the legal challenges of promoting recycled plastics, and the geopolitics of critical minerals for clean energy. These works reflect a multidisciplinary trend integrating law with environmental science, public health, and policy analysis. Her scientific recognition includes being appointed as a Visiting Lecturer at the University of Bayreuth in 2018. This honor reflects her international standing in legal academia. She actively supervises PhD students on topics such as renewable energy policy, hydraulic fracturing, and legal translation. Her research is supported by major grants from the European Commission and the UK’s Engineering and Physical Science Research Council (EPSRC), including projects like RECREATE and PrecisionTox, which aim to transform regulatory science and sustainability law. She leads and co-leads major interdisciplinary initiatives such as the Health-centred Systems Approach towards Net-Zero (Heal-NZ) and the development of a circular economy for medical plastics, demonstrating her role in bridging law with science and public health.

• Toxicology
• Environmental Toxicology
• Nanomaterial Toxicity
• +3 more

Hans Bouwmeester is a Full Professor in Toxicology at Wageningen University & Research, specializing in chemical risk assessment, nanomaterial toxicity, and in vitro modeling. His work focuses on integrating artificial intelligence and physiologically based kinetic (PBK) models to predict toxic effects of contaminants like organophosphate pesticides, microplastics, and mycotoxins. He leads projects exploring the health impacts of foodborne contaminants in inflammatory bowel disease and developing animal-free testing methods. Key collaborations include EU initiatives like the ONTOX project and the GUTTEST program, which utilize advanced in vitro models such as gut-on-a-chip systems. Research interests span toxicokinetics, nanoplastics exposure, and the application of Bayesian networks for nanomaterial hazard ranking. His team addresses translational challenges in linking in vitro data to in vivo outcomes, with a focus on bile acid metabolism and cardiotoxicity prediction. Bouwmeester has supervised over 10 PhD candidates, including studies on microplastic hazard assessment, nanomaterial gastrointestinal fate, and AI-driven data extraction for risk assessment. Notable contributions include datasets on nanoplastics' protein corona effects and transcriptomic analyses of intestinal cell responses. His work is published in journals like Ecotoxicology and Environmental Safety , Toxicology , and Environmental Science & Technology , emphasizing open-access research and interdisciplinary approaches to chemical safety.

Tiina SikanenView profile

Associate Professor

• Microfluidic Total Analysis Systems
• Digital Microfluidics
• Polymer Microfabrication
• +5 more

Tiina Sikanen is an Associate Professor at the University of Helsinki within the Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology . She leads the Chemical Microsystems Lab and serves as a supervisor for doctoral programmes in Drug Research, Chemistry and Molecular Sciences, and Materials Research and Nanosciences. Her research focuses on microfluidic systems, polymer microfabrication, and mass spectrometry applications in drug metabolism studies. Education : MSc in Chemical Technology (Aalto University, 2010), PhD in Pharmaceutical Chemistry (University of Helsinki, 2007) Her research integrates microfluidic total analysis systems with digital microfluidics to create 3D liver and cardiac cell culture models for studying extracellular vesicle activity and cytochrome P450 metabolism. Key projects include PREMIER (risk evaluation of medicines in environment) and CardioEV (cardiotoxicity biomarker discovery). Her recent publications highlight advancements in microdevice-based extracellular vesicle quantitation, Staphylococcus biofilm modeling, and sustainable pharmaceutical life-cycle analysis. Scientific awards include the Academy of Finland Award for Scientific Courage (2019) , Research Fellow (2017) , and Postdoctoral Researcher (2011) . She has supervised numerous Master's and doctoral theses, including Elina Kyllönen's MSc(Pharm) work on microfluidic sustainability challenges and Laura Sirviö's BSc research. Her lab employs 3D printing for cleanroom-free microdevice fabrication and participates in EU-funded initiatives like IMI2-RIA PREMIER.

Beate EscherView profile

Professor

• Environmental Toxicology
• In Vitro Bioassays
• New Approach Methods (NAMs)
• +12 more

Prof. Dr. Beate Escher is Head of the Department of Cell Toxicology at the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, Germany. She holds professorial positions at Eberhard Karls University of Tübingen , is a Privatdozent at ETH Zurich , and is affiliated with the University of Queensland and Griffith University in Australia. Her research program focuses on advancing in vitro bioassays and New Approach Methods (NAMs) for environmental and human health risk assessment of micropollutants. Her research interests lie at the intersection of environmental toxicology , molecular toxicology , and exposure science . She develops and applies bioanalytical tools for water quality assessment, with a focus on pharmaceuticals, pesticides, and transformation products. Her work includes mechanism-based toxicity assessment , toxicokinetic-toxicodynamic (TKTD) modeling , and the development of the CITEPro robotic bioassay platform for high-throughput screening. She integrates omics data , computational modeling , and machine learning to improve chemical hazard characterization. Recent publications highlight trends in chemical mixture toxicity , safe-by-design chemicals , ionic compound assessment , and machine learning applications in toxicology. Her work increasingly leverages data-driven approaches to prioritize contaminants and predict biological effects across species. Scientific Awards: Highly Cited Researcher (Web of Science/Clarivate, Top 0.1%, 2020) Outstanding Achievements in Environmental Science and Technology (ES&T & ACS ENVR, 2023) Advising and Grants: She supervises multiple doctoral students and leads major collaborative projects such as InCeTo, MibiTox, nanoINHALE, and SafePol. She received an Australian Research Council grant (2011–2014) and leads Swiss National Science Foundation-funded initiatives. She was a member of the German Science Council (2017–2024) and serves on the Board of Reviewing Editors of SCIENCE . Labs and Teams: She leads the Cell Toxicology team at UFZ, which includes researchers such as Dr. Luise Henneberger, Dr. Julia Huchthausen, and Dr. Haotian Wang. The team operates the CITEPro platform and contributes to international consortia focused on exposome research and chemical safety.

Shana SturlaView profile

Professor

• Toxicology
• Molecular Toxicology
• Environmental Toxicology
• +6 more

Prof. Shana Sturla is a Full Professor at the Department of Health Sciences and Technology (D-HEST) at ETH Zurich. Her research focuses on understanding human toxicity through the lens of chemical structure-reactivity relationships, with a particular emphasis on dietary chemicals and nucleic acid interactions. Her work bridges toxicology, biochemistry, and molecular biology, aiming to elucidate mechanisms linking chemical exposure to cancer initiation and treatment. Research interests include Mechanisms of mutagenesis via DNA-damaging agents Biomarkers for precision cancer therapy Safety assessment of nanomaterials Gut microbiota-mediated chemical toxicity Systems toxicology approaches for exposure modeling Recent studies highlight her lab's work on DNA repair pathways (e.g., MGMT protein function), microbiome-driven metabolism of dietary carcinogens, and PBK modeling to predict internal exposure. Her interdisciplinary approach combines synthetic chemistry, bioanalytical techniques, and computational modeling to address translational toxicology challenges. Key methodologies include Genome-wide DNA damage mapping In vitro-to-in vivo extrapolation High-content imaging for toxicity assessment Physiologically based kinetic modeling No scientific awards or grants are explicitly listed in the provided text, but her extensive publication record reflects significant contributions to toxicology and cancer biology.

Natacha HoganView profile

Associate Professor

• Environmental Toxicology
• Aquatic Toxicology
• Animal Health
• +3 more

Dr. Natacha Hogan is an Associate Professor (with Tenure) in the Department of Animal and Poultry Science at the University of Saskatchewan, within the College of Agriculture and Bioresources. She holds roles as Chair and Academic Advisor for Undergraduate Programs in Animal Science and Animal Bioscience, as well as Co-Chair and Academic Advisor for the BSc Toxicology Program in the College of Arts and Science. Dr. Hogan earned a Ph.D. in Biology (Specialization in Chemical and Environmental Toxicology) from the University of Ottawa in 2007 and a B.Sc. (Biology, Honours) from the University of Prince Edward Island in 2000. Her research focuses on understanding the impact of anthropogenic and natural contaminants on animal health, with a particular emphasis on aquatic systems and production animals like poultry and swine. Key areas include contaminant toxicity thresholds, mycotoxin mitigation, and the development of new approach methods (NAMs) for chemical risk assessment. Her work integrates physiology, molecular biology, and toxicology to address environmental and health impacts of contaminants. Recent studies explore the effects of antimicrobial exposure on fish gut microbiomes, pesticide synergism in complex mixtures, and the neurodegenerative potential of pesticides. Dr. Hogan has received prestigious awards, including the Provost’s College Award for Outstanding Teaching (2024 and 2018) and the North American Colleges and Teachers of Agriculture Teaching Award of Merit (2023 and 2017). She leads the Hogan Lab, a multidisciplinary group advancing toxicogenomics tools like EcoToxChip for environmental management and chemical risk assessment. Her research has been supported by organizations such as NSERC, Mitacs, Environment and Climate Change Canada, and the Canadian Foundation for Innovation. She teaches courses including Introductory Animal Bioscience, Comparative Animal Endocrinology, and Toxicology Research, emphasizing hands-on learning and interdisciplinary collaboration. The Hogan Lab actively engages in both fundamental and applied research, aiming to bridge scientific discovery with practical solutions for improving environmental quality and animal health.

• Toxicology
• Pharmacology
• Renal Toxicology
• +5 more

Tara McMorrow is an Associate Professor of Pharmacology and Toxicology at University College Dublin's School of Biomolecular and Biomedical Science and a Conway Research Fellow. She serves as Director of the UCD Centre for Toxicology and Academic Director of graduate programs in Toxicology and Regulatory Affairs. Previously, she was Associate Dean of Science (2019-2024) and Chair of the UCD Academic Council Committee on Student Appeals and Complaints. Dr. McMorrow earned her BSc and PhD in Science from NUI Galway, with her 1995 PhD focusing on molecular biology funded by Enterprise Ireland. She completed postdoctoral work at Erasmus University in Rotterdam and at UCD before being appointed Lecturer in Pharmacology in 2005. She was promoted to Senior Lecturer in 2014 and Associate Professor in 2016. She also earned a Graduate Diploma in University Teaching and Learning from UCD in 2013. Her research focuses on toxicology and the development of new approach methodologies (NAMs) in toxicity testing, with particular expertise in renal toxicology, chemical carcinogenesis, primary cilia biology, and biomarker discovery. Her work bridges basic science and clinical applications, examining mechanisms of kidney injury, diabetic nephropathy, and renal cancer. Analysis of her recent publications reveals strong emphasis on natural compounds like curcumin for cancer therapy, primary cilia as biomarkers for renal injury, and mechanisms of chemical-induced kidney damage. Dr. McMorrow has received numerous teaching awards including Teacher of the Year in 2013 and 2016, and has been recognized with UCD Seed Funding. She serves as an expert member of the Food Safety Authority of Ireland's Chemical Safety sub-committee and is active in professional organizations including the Irish Society of Toxicology (where she served as President 2016-2018) and the European Society of Toxicologists. She actively teaches across multiple disciplines including Science, Medicine, Nursing, and graduate programs in Toxicology, Regulatory Affairs, and Biotechnology. Her leadership extends to curriculum development as she was previously the Curriculum Review and Enhancement Project Champion for graduate taught programs in the College of Science (2015-2017).

Ellen MoorsView profile

Professor

• Sustainable Innovation
• Governance of Emerging Technologies
• Sustainable Healthcare
• +5 more

Ellen Moors is a Full Professor of Innovation and Sustainability and Head of the Department of Geosciences at Utrecht University's Copernicus Institute of Sustainable Development. She leads research on socio-technical transitions in health, agri-food, and life sciences, focusing on governance, user innovation, and responsible research and innovation (RRI). Her work emphasizes societal challenges, institutional frameworks, and co-creation with stakeholders to ensure sustainable outcomes. Affiliations : Dutch Advisory Board for Science, Technology and Innovation (AWTI); Committee on Genetic Modification (COGEM); Board Member of Future Food Utrecht. Education : Not explicitly detailed in provided texts, but her academic roles imply advanced degrees in sustainability and innovation studies. Her research areas include governance of emerging technologies, sustainable healthcare innovations, and interdisciplinary pathways to sustainability. She has over 80 publications in journals like Research Policy and Nature Biotechnology , and co-edited a book on Alzheimer's diagnostics. Her teaching spans bachelor and master programs in innovation management and sciences. Research Interests : Intersection of innovation theory and sustainability, with a focus on: Legitimation of socio-technical transitions User-producer interactions in healthcare and agriculture Regulatory frameworks for emerging technologies AI ethics and responsible innovation in long-term care Recent Projects : VHP4Safety (chemical safety via human data), AI-assisted decision-making in dementia care, and triple artemisinin therapy deployment in malaria-prone regions. These projects emphasize human-centered design and policy integration.

• Cell Biology
• Toxicology
• Tissue Engineering
• +3 more

Dr. Carine Gaiser is a Researcher at the School of Life Sciences, FHNW University of Applied Sciences and Arts Northwestern Switzerland. She is affiliated with the Institute for Chemistry and Bioanalytics, focusing on cell biology and in vitro toxicology. Her research employs cell cultures and tissue engineering to investigate disease mechanisms and substance efficacy/toxicity. Key collaborations include work on blood-brain barrier models, neuroregenerative scaffolds, and liver toxicity pathways. Her research interests span regenerative medicine, drug toxicity assessment, and biomarker discovery for fibrosis. She contributes to 'New Approach Methodology' (NAM) initiatives promoting non-animal testing strategies. Dr. Gaiser has published on topics ranging from miRNA roles in liver fibrosis to 3D cell culture platforms for high-throughput screening. Her work emphasizes translational applications, including in vitro models for drug development and tissue engineering innovations. She has presented findings at conferences like the ASHP Midyear Meeting and collaborates with interdisciplinary teams to advance alternative toxicology methods.

Tiendung LeView profile

Associate Professor

• Project Management
• Front End Planning
• Risk Management
• +9 more

Dr. Tiendung (TJ) Le is an Associate Professor at RMIT University's School of Property, Construction and Project Management. He is a pioneer in applying the case method in project management education and leads the Front End Planning (FEP) research group. He serves as Program Manager for RMIT's Master of Project Management program. His research focuses on front-end planning, risk management, cross-cultural project management, and construction safety. Dr. Le holds a Ph.D. in Civil Engineering from the University of Texas at Austin, an M.Sc. from the Asian Institute of Technology, and an MBA from the University of Technology Sydney. He has held senior roles in Vietnam's construction industry and co-founded LEAD Consulting JSC. **Career Highlights**: - Co-Founder & Partner, LEAD Consulting JSC (2011–present) - Deputy Director, Nam Long Investment Corporation (2013–2014) - Deputy Managing Director, HUAIC Infrastructure Development (2010–2013) **Research Interests**: - Front-end planning decision frameworks - Cross-cultural project teams - BIM and lean construction integration - Sustainable infrastructure procurement - Project management education innovations **Teaching & Engagement**: - Teaches Project Initiation Management, Agile Project Management, and Project Procurement Ethics - Served on PMI Melbourne Chapter Board (2019–present) - Member of ISO/TC 342 Management Consultancy Committee - Contributes to CIB W107 Commission on Construction in Developing Countries **Key Contributions**: - Developed FEP frameworks for infrastructure projects in developing countries - Authored over 30 peer-reviewed publications on project management topics - Supervised research on BIPV deployment and IPD collaboration in Australia

Anja WilmesView profile

Assistant Professor

• Toxicology
• Molecular Toxicology
• Human Cell Culture Models
• +7 more

Anja Wilmes is an Assistant Professor at the Vrije Universiteit Amsterdam in the Faculty of Science, Department of Chemistry and Pharmaceutical Sciences, and part of the AIMMS research institute, specializing in Molecular and Computational Toxicology with expertise in human cell-based toxicity testing models. Education: PhD in Cell and Molecular Biology from Victoria University of Wellington, New Zealand (supervised by Prof. John H. Miller) Habilitation (venia docendi) in Physiology from Medical University of Innsbruck, Austria (2016) Her research pioneers New Approach Methodologies (NAMs) using advanced human cell culture systems, including primary renal cells, iPSC-derived renal proximal tubular-like cells, podocytes, hepatocytes, endothelial cells, and cardiomyocytes. She develops microporous growth supports and microphysiological systems (organ-on-a-chip) to study personalized medicine, renal transport mechanisms, drug metabolism, and cellular stress responses through transcriptomics, High Content Imaging, and Seahorse mitostress assays. Recent publications demonstrate consistent innovation in iPSC-based toxicity models, mitochondrial dysfunction analysis, and adverse outcome pathway assembly for renal and hepatic toxicity. Scientific Awards: Otto Kraupp Preis (2017) As Master coordinator for the Molecular Toxicology track in the DDS program, she leads courses in Human Cells in Culture and Induced Pluripotent Stem Cells in Toxicology. Her research leadership spans major EU projects including Predict-IV, StemBANCC, EU-ToxRisk, RISK-HUNT3R, VHP4Safety, and ADME4NGRA, alongside project leadership in Stiftung Set and ProCare initiatives. She serves as Associate Editor for Elsevier since 2025. Her laboratory focuses on developing animal-free toxicity testing platforms through advanced cell culture engineering and stem cell differentiation protocols, directly contributing to sustainable drug development and regulatory science.

Prashant DograView profile

Assistant Clinical Professor

• Mathematical Modeling
• Quantitative Systems Pharmacology
• Data Science
• +7 more

Prashant Dogra serves as Assistant Professor of Clinical Pharmacy and Associate Director of the Center for Quantitative Drug and Disease Modeling at the University of Southern California's Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, where he bridges pharmaceutical sciences, biomedical engineering, and data science to advance drug development. His educational credentials include: PhD from The University of New Mexico BPharm from Panjab University Dr. Dogra's research pioneers New Approach Methodologies (NAMs) integrating multiscale mechanistic modeling, quantitative systems pharmacology (QSP), and artificial intelligence to solve critical challenges in nanomedicine and therapeutics. His lab focuses on AI-guided nanoparticle design for organ-specific targeting, systems modeling for personalized cancer treatment, and vaccination optimization strategies. This interdisciplinary work leverages mathematical modeling and machine learning to transform translational pharmacology through computational prediction of drug behavior. He currently leads NIH-funded research including an R01 grant (1R01EB035545) from the National Institute of Biomedical Imaging and Bioengineering supporting his PBPK-Tox modeling framework for nanoparticle safety prediction. Dr. Dogra actively cultivates interdisciplinary collaborations and recruits students from computational and biomedical backgrounds to join his lab's mission of accelerating nanomaterial translation through rational design.

Joonseong LeeView profile

Professor

• Media Studies
• New Media Technologies
• Cultural Studies
• +7 more

Dr. Joonseong Lee is a Professor in the Department of Communication & Media Studies at California State University San Marcos, part of the College of Humanities, Arts, Behavioral and Social Sciences (CHABSS). His office is located in SBSB 2128, and he can be contacted via email at jlee@csusm.edu or phone at (760) 750-4134. Education Ph.D. in Media Studies (2006) from Ohio University, School of Media Arts and Studies M.A. in Radio and Television (2002) from San Francisco State University, College of Creative Arts B.A. in Won Buddhism (1988) from Won Kwang University, Korea, focusing on Buddhism and social movements Research Focus Dr. Lee specializes in media, religion, and pop culture with expertise in emerging media and Eastern philosophy. His research combines Continental philosophy with Buddhist and Taoist frameworks to analyze: New media technologies and governmental dominance Feminist media studies and cyberculture empowerment Korean shamanism's mediatization and territorialization processes Cultural implications of digital spirituality and online rituals His groundbreaking 2022 book The Assemblage of Korean Shamanism examines shamanic practices through Deleuzian frameworks, with forthcoming research on artist Nam June Paik as an 'electronic shaman' (2025). Publication Focus Dr. Lee's scholarly work consistently explores the intersection of traditional Korean culture with digital modernity. His publications demonstrate: Recurrent analysis of shamanism's adaptation to digital capitalism Critical examination of gender politics in online spaces Interdisciplinary approaches combining media theory with religious studies Sustained focus on Korean cultural identity in globalized media landscapes Methodological innovation in studying cybercultures and digital ethnography Teaching Portfolio MDIA 360: Media and Society MDIA 301: Media Theory MDIA 304: Global Media MDIA 451: Media, Religion & Pop Culture MDIA 452: Media Ethics

• Endocrine toxicology
• Endocrine-disrupting chemicals
• Molecular pathways regulating energy metabolism
• +10 more

Dr. Jorke Kamstra is an Associate Professor at the Division of Toxicology, Institute for Risk Assessment Sciences (IRAS), Faculty of Veterinary Medicine, Utrecht University, where he leads the endocrine toxicology team. His research focuses on understanding how endocrine-disrupting chemicals (EDCs) interfere with molecular pathways regulating energy metabolism and cellular differentiation, particularly in metabolic diseases such as obesity and type 2 diabetes. Dr. Kamstra received his PhD from the Norwegian University of Life Sciences (NMBU) in 2017, where he studied transgenerational effects of environmental stress via epigenetic inheritance in zebrafish. Before his PhD, he worked for over a decade as a research technician at the Institute for Environmental Studies, Vrije Universiteit Amsterdam. In 2014, he earned his MSc in Molecular Cell Biology cum laude. His research centers on how metabolic disruptors act on transcriptional and epigenetic regulatory networks, influencing gene expression programs and shaping phenotypes. He is particularly interested in epigenetic reprogramming's role in mediating persistent or transgenerational effects of EDCs. His team combines mechanistic toxicology with systems-level approaches to uncover critical pathways underlying EDC-induced metabolic dysfunction. They develop and apply in vitro models or new approach methodologies (NAMs) to study effects on adipocyte, liver, and pancreas to identify chemical stressors with metabolism-disrupting potential. Current research topics include EDC effects on fatty liver disease (EDC-MASLD), BPA alternatives' effects on adiposity via PPAR gamma (PARC), and PFAS effects on adipogenesis and pancreas (AFARA). Analysis of Dr. Kamstra's publication record reveals a strong focus on epigenetic mechanisms of endocrine disruption, transgenerational effects, and metabolism-disrupting chemicals. His work spans from fundamental molecular mechanisms to applied risk assessment, with increasing emphasis on developing standardized in vitro models for regulatory purposes. Recent publications show growing interest in microplastics and nanoplastics effects on reproduction and early development. Dr. Kamstra has published extensively in high-impact journals, with his work cited widely in the fields of toxicology, epigenetics, and environmental health. His research has contributed significantly to understanding how environmental chemicals disrupt metabolic pathways through epigenetic mechanisms. He is actively involved in teaching courses including Advanced Toxicology and Health Effects Toxicology - Food, Pesticides and Drugs. His team includes PhD students and postdoctoral researchers working on various aspects of endocrine and metabolic disruption, contributing to the development of innovative, animal-free approaches for chemical safety assessment.

Samar R El KhoudaryView profile

Professor

• Cardiovascular Epidemiology
• Women's Health
• Menopause Transition
• +5 more

Samar R El Khoudary serves as Professor and Vice Chair for Education in the Department of Epidemiology at the University of Pittsburgh School of Public Health, with additional affiliation at the Clinical and Translational Science Institute. An established cardiovascular and women's health epidemiologist, she leads research establishing the menopause transition as a critical period for cardiovascular disease risk acceleration through hormonal and physiological changes. Her educational background includes: 1998: BPharm in Pharmacy, Al-Azhar University (Gaza, Palestine) 2002: MPH in Epidemiology and Biostatistics, Al-Quds University (Gaza, Palestine) 2008: PhD in Epidemiology, University of Pittsburgh Dr. El Khoudary's research centers on disentangling chronological aging from ovarian aging effects using the SWAN cohort, with expertise in complex statistical methodologies for longitudinal data. Her work demonstrates how menopause-related changes in sex hormones, lipids, visceral fat, and vascular properties collectively increase cardiovascular risk. She has developed innovative analytical approaches to isolate menopause-specific effects from aging processes. Her recent publications (2019-2023) reveal consistent patterns linking menopause transition timing to accelerated cardiovascular changes, particularly in blood pressure trajectories, arterial stiffness, and lipid profiles. These studies consistently identify the perimenopausal period as a critical window for cardiovascular risk assessment, with implications for early prevention strategies emphasized in her American Heart Association scientific statement. Scientific recognition includes: Fulbright PhD Scholarship (2004-2007) AHA Fellow (FAHA, 2015) Pitt Public Health Alumni Research Award (2023) NAMS New Investigator Award (2012) Multiple Trudy Bush Fellowships and poster prizes She mentors students and junior faculty while leading departmental curriculum improvements, having directed Epidemiological Methods courses since 2014. Her service includes editorial roles for Menopause and JAHA , scientific program committees for AHA and NAMS, and contributions to the 2022 Hormone Therapy Position Statement. As SWAN study lead for cardiovascular analyses, she coordinates this critical multi-center cohort investigating midlife women's health trajectories.